Indeed, it has been demonstrated that the peptide BCL-2-IP3R disruptor 2 (BIRD-2) is capable of blocking the interaction between Bcl-2 and IP3Rs, thus triggering proapoptotic Ca2+ signaling in cancer cells [238,239]. This evidence concerns the gene BCL2 and cancer.